Treatment of brain tumors with iridium-192 seeds. 1988

I Kaneko, and M Noguchi, and T Kogure, and T Aoyagi, and H Terao, and T Seki, and A Ogasawara
Department of Radiology, Toho University School of Medicine, Tokyo, Japan.

Interstitial radiation therapy of brain tumors requires positioning of the radioactive sources with good precision in order to achieve a sufficient dose in the tumor without too much damage to surrounding tissues. A method for application of 192Ir seeds in brain tumors is described and preliminary results in seven patients reported. The method, which uses CT-guided stereotactic localization and computerized dose planning, is at present fairly complicated. The preliminary results are promising and no serious complications have so far been observed.

UI MeSH Term Description Entries
D007496 Iridium Radioisotopes Unstable isotopes of iridium that decay or disintegrate emitting radiation. Ir atoms with atomic weights 182-190, 192, and 194-198 are radioactive iridium isotopes. Radioisotopes, Iridium
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D001918 Brachytherapy A collective term for interstitial, intracavity, and surface radiotherapy. It uses small sealed or partly-sealed sources that may be placed on or near the body surface or within a natural body cavity or implanted directly into the tissues. Curietherapy,Implant Radiotherapy,Plaque Therapy, Radioisotope,Radioisotope Brachytherapy,Radiotherapy, Interstitial,Radiotherapy, Intracavity,Radiotherapy, Surface,Brachytherapy, Radioisotope,Interstitial Radiotherapy,Intracavity Radiotherapy,Radioisotope Plaque Therapy,Radiotherapy, Implant,Surface Radiotherapy,Therapy, Radioisotope Plaque
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

I Kaneko, and M Noguchi, and T Kogure, and T Aoyagi, and H Terao, and T Seki, and A Ogasawara
November 1961, Radiology,
I Kaneko, and M Noguchi, and T Kogure, and T Aoyagi, and H Terao, and T Seki, and A Ogasawara
December 1986, International journal of radiation oncology, biology, physics,
I Kaneko, and M Noguchi, and T Kogure, and T Aoyagi, and H Terao, and T Seki, and A Ogasawara
November 1980, Urology,
I Kaneko, and M Noguchi, and T Kogure, and T Aoyagi, and H Terao, and T Seki, and A Ogasawara
June 1988, Praxis und Klinik der Pneumologie,
I Kaneko, and M Noguchi, and T Kogure, and T Aoyagi, and H Terao, and T Seki, and A Ogasawara
January 1975, Nowotwory,
I Kaneko, and M Noguchi, and T Kogure, and T Aoyagi, and H Terao, and T Seki, and A Ogasawara
February 1999, Chinese medical journal,
I Kaneko, and M Noguchi, and T Kogure, and T Aoyagi, and H Terao, and T Seki, and A Ogasawara
January 1985, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
I Kaneko, and M Noguchi, and T Kogure, and T Aoyagi, and H Terao, and T Seki, and A Ogasawara
October 1997, Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale,
I Kaneko, and M Noguchi, and T Kogure, and T Aoyagi, and H Terao, and T Seki, and A Ogasawara
March 1977, Journal of the National Medical Association,
I Kaneko, and M Noguchi, and T Kogure, and T Aoyagi, and H Terao, and T Seki, and A Ogasawara
January 1985, Deutsche Zeitschrift fur Mund-, Kiefer- und Gesichts-Chirurgie,
Copied contents to your clipboard!